"Bile Ducts, Intrahepatic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Passages within the liver for the conveyance of bile. Includes right and left hepatic ducts even though these may join outside the liver to form the common hepatic duct.
MeSH Number(s)
A03.159.183.158
A03.620.150
Concept/Terms
Bile Ducts, Intrahepatic- Bile Ducts, Intrahepatic
- Bile Duct, Intrahepatic
- Duct, Intrahepatic Bile
- Ducts, Intrahepatic Bile
- Intrahepatic Bile Duct
- Intrahepatic Bile Ducts
Below are MeSH descriptors whose meaning is more general than "Bile Ducts, Intrahepatic".
Below are MeSH descriptors whose meaning is more specific than "Bile Ducts, Intrahepatic".
This graph shows the total number of publications written about "Bile Ducts, Intrahepatic" by people in Harvard Catalyst Profiles by year, and whether "Bile Ducts, Intrahepatic" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 1 | 1 | 2 |
1996 | 4 | 0 | 4 |
1997 | 1 | 1 | 2 |
1998 | 3 | 0 | 3 |
1999 | 1 | 0 | 1 |
2000 | 2 | 0 | 2 |
2002 | 1 | 3 | 4 |
2003 | 2 | 2 | 4 |
2004 | 2 | 0 | 2 |
2005 | 3 | 0 | 3 |
2006 | 4 | 1 | 5 |
2007 | 2 | 1 | 3 |
2008 | 3 | 1 | 4 |
2009 | 1 | 1 | 2 |
2010 | 2 | 0 | 2 |
2011 | 2 | 1 | 3 |
2012 | 5 | 1 | 6 |
2013 | 5 | 6 | 11 |
2014 | 4 | 6 | 10 |
2015 | 3 | 3 | 6 |
2016 | 1 | 2 | 3 |
2017 | 2 | 1 | 3 |
2018 | 2 | 3 | 5 |
2019 | 3 | 1 | 4 |
2020 | 0 | 4 | 4 |
2021 | 2 | 10 | 12 |
2022 | 0 | 16 | 16 |
2023 | 1 | 16 | 17 |
2024 | 0 | 1 | 1 |
Below are the most recent publications written about "Bile Ducts, Intrahepatic" by people in Profiles.
-
Landscape of Clinical Resistance Mechanisms to FGFR Inhibitors in FGFR2-Altered Cholangiocarcinoma. Clin Cancer Res. 2024 Jan 05; 30(1):198-208.
-
Deep learning-based phenotyping reclassifies combined hepatocellular-cholangiocarcinoma. Nat Commun. 2023 Dec 14; 14(1):8290.
-
Incremental value of volumetric multiparametric MRI over Fudan score for prognosis of unresectable intrahepatic cholangiocarcinoma treated with systemic chemotherapy. Eur J Radiol. 2024 Jan; 170:111196.
-
Independent of Primary Sclerosing Cholangitis and Cirrhosis, Early Adulthood Obesity Is Associated with Cholangiocarcinoma. Cancer Epidemiol Biomarkers Prev. 2023 10 02; 32(10):1338-1347.
-
RLY-4008, the First Highly Selective FGFR2 Inhibitor with Activity across FGFR2 Alterations and Resistance Mutations. Cancer Discov. 2023 09 06; 13(9):2012-2031.
-
The Cholangiocarcinoma in the Young (CITY) Study: Tumor Biology, Treatment Patterns, and Survival Outcomes in Adolescent Young Adults With Cholangiocarcinoma. JCO Precis Oncol. 2023 08; 7:e2200594.
-
Natural Flavonoids Quercetin and Kaempferol Targeting G2/M Cell Cycle-Related Genes and Synergize with Smac Mimetic LCL-161 to Induce Necroptosis in Cholangiocarcinoma Cells. Nutrients. 2023 Jul 10; 15(14).
-
Molecular profiling and treatment pattern differences between intrahepatic and extrahepatic cholangiocarcinoma. J Natl Cancer Inst. 2023 07 06; 115(7):870-880.
-
NCCN Guidelines® Insights: Biliary Tract Cancers, Version 2.2023. J Natl Compr Canc Netw. 2023 07; 21(7):694-704.
-
Major Postoperative Complications Limit Adjuvant Therapy Administration in Patients Undergoing Pancreatoduodenectomy for Distal Cholangiocarcinoma or Pancreatic Ductal Adenocarcinoma. Ann Surg Oncol. 2023 Aug; 30(8):5027-5034.